Ackman Is Said to See Need for Cost Cutting at Zoetis
This article is for subscribers only.
Bill Ackman, the activist investor who has taken a stake in Zoetis Inc., sees a large opportunity to cut costs at the animal drug company, according to people at a private meeting with investors where Ackman spoke.
Ackman hasn’t yet met with Zoetis’s management, according to one person familiar with his plans. The people asked not to be identified because the matter is private.